Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.22 USD | +0.10% | -11.24% | -40.13% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.13% | 3.68B | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+40.06% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- JPMorgan Starts Coverage on Immunovant With Overweight Rating, $51 Price Target